Medical Imaging (MEDD) Competitors

bioAffinity Technologies (NASDAQ:BIAFW) and Medical Imaging (OTCMKTS:MEDD) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their community ranking, institutional ownership, dividends, risk, earnings, analyst recommendations, media sentiment, valuation and profitability.

Does the MarketBeat Community prefer BIAFW or MEDD?

Medical Imaging received 54 more outperform votes than bioAffinity Technologies when rated by MarketBeat users.

Company	Underperform	Outperform
bioAffinity Technologies	N/A	N/A
Medical Imaging	Outperform Votes 54 61.36%	Underperform Votes 34 38.64%

Does the media refer more to BIAFW or MEDD?

In the previous week, Medical Imaging had 1 more articles in the media than bioAffinity Technologies. MarketBeat recorded 1 mentions for Medical Imaging and 0 mentions for bioAffinity Technologies. bioAffinity Technologies' average media sentiment score of 1.89 beat Medical Imaging's score of 0.00 indicating that bioAffinity Technologies is being referred to more favorably in the media.

Company	Overall Sentiment
bioAffinity Technologies	Very Positive
Medical Imaging	Neutral

Do analysts recommend BIAFW or MEDD?

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
bioAffinity Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Medical Imaging	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Which has better earnings and valuation, BIAFW or MEDD?

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
bioAffinity Technologies	$5.72 thousand	N/A	N/A	N/A	N/A
Medical Imaging	N/A	N/A	N/A	-$0.00	-0.12

Do institutionals & insiders have more ownership in BIAFW or MEDD?

20.2% of Medical Imaging shares are held by institutional investors. 1.2% of Medical Imaging shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Is BIAFW or MEDD more profitable?

Company	Net Margins	Return on Equity	Return on Assets
bioAffinity Technologies	N/A	N/A	N/A
Medical Imaging	N/A	N/A	N/A

Summary

Medical Imaging beats bioAffinity Technologies on 4 of the 6 factors compared between the two stocks.